Status:
COMPLETED
Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the (cost)effectiveness of mindfulness based cognitive therapy (MBCT) compared to that of antidepressant medication, and its combination with regard to the ...
Detailed Description
In the Netherlands, treatment as usual for patients with (recurrent) Major Depressive Disorder consists of maintenance antidepressant medication. Mindfulness-based cognitive therapy (MBCT) is a recent...
Eligibility Criteria
Inclusion
- Recurrent Major Depressive Episode (at least 3 previous episodes)
- Treatment with therapeutic dose of antidepressant medication during past six months
- Currently in full or partial remission
Exclusion
- Bipolar disorder (current and previous (hypo)manic episodes)
- Psychotic disorder (current and previous)
- Neurological or somatic illness affecting depression or outcome measures
- Current alcohol or drugs dependency
- Use of high dosage benzodiazepines (\> 2 mg Lorazepam equivalents daily)
- Recent Electro Convulsive Therapy (\< 3 months ago)
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT00928980
Start Date
May 1 2009
End Date
June 1 2013
Last Update
November 13 2020
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Pro Persona
Arnhem, Gelderland, Netherlands, 6800
2
Pro Persona
Ede, Gelderland, Netherlands
3
Radboud University Nijmegen Medical Center
Nijmegen, Gelderland, Netherlands, 6525 GC
4
Pro Persona
Tiel, Gelderland, Netherlands